US 9028819
Methods of alleviating itch by administering human antibodies to human protease-activated receptor 2
granted A61KA61K2039/505A61K39/3955
Quick answer
US patent 9028819 (Methods of alleviating itch by administering human antibodies to human protease-activated receptor 2) held by REGENERON PHARMACEUTICALS, INC. expires Mon May 07 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue May 12 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 07 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 26
- CPC classes
- A61K, A61K2039/505, A61K39/3955, A61K45/06, A61P